Systemic Mastocytosis With Associated Acute Myeloid Leukemia Identified After Induction Therapy: A Case Report and Literature Review.
文献摘要
Systemic mastocytosis (SM) is a rare clonal mast cell disorder, with the vast majority of cases driven by activating KIT mutations, that can coexist with other myeloid hematologic malignancies. There are multiple subtypes of SM, one of which is SM with an associated hematologic neoplasm (SM-AHN), which is the coexistence of SM and a separate neoplasm, often driven by a shared clonal origin. We report the case of a 48-year-old man who initially presented with profound leukocytosis, anemia, and thrombocytopenia and was subsequently diagnosed with AML. After undergoing induction chemotherapy, the patient was found to have less than 5% blasts but perivascular clusters of CD25-positive and CD117-positive cells on a day-14 bone marrow biopsy that were not previously seen, establishing the diagnosis of SM-AML. The patient is currently undergoing consolidation with consideration of allogeneic stem cell transplantation and potential additional maintenance therapy for SM. SM-AHN is a rare entity that has been reported in the literature; however, given its rarity, it does not have a well-established understanding of the drivers of malignancy, risk stratification, and prognostication, among other aspects that are better understood in more common malignancies. Here, we present a case of SM-AHN to contribute to the current literature and improve understanding of this rare entity.